Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (2350)	11/10/1997 5:40:00 PM
From: don roberson	Read Replies (1) \| Respond to of 23519

And it is this extended duration, when discussed at the "water cooler" that will prove to be what the "guys", and if truthful "gals" will prefer. We have speculated that the extended duration will be preferred. Now with the NW article, we have the first declaration. No matter how hard PFE pushes the VIAGRA, the market place will win out. The users will make the choice. The pill, on first glance, seems the best, but its the performance that will win out, NOT the application technique. There is too much difference in the "pleasure" area. Just as folks will be surprised at the enormous demand that is to come, they will also be with the choice. Local over Pill. The journalists will be eating crow again. I think they will be wrong again, because I've heard that most journalsits don't have sex. They are just too biased to share a moment.